Packer, Milton http://orcid.org/0000-0003-1828-2387
Article History
Received: 9 August 2019
Accepted: 12 September 2019
First Online: 24 September 2019
Ethics approval and consent to participate
: Not applicable.
: There is only one author who takes full responsibility for the work and consents to its submission.
: Dr. Packer has recently consulted for Abbvie, Actavis, Akcea, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Cardiorentis, Daiichi Sankyo, Gilead, Johnson & Johnson, NovoNordisk, Pfizer, Relypsa, Sanofi, Synthetic Biologics and Theravance. None of these relationships are relevant to the topic of this manuscript.